Bfsg LLC Invests $53,000 in Embecta Corp. (NASDAQ:EMBC)

Bfsg LLC bought a new position in Embecta Corp. (NASDAQ:EMBC) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 2,776 shares of the company’s stock, valued at approximately $53,000.

Several other hedge funds have also recently modified their holdings of the stock. Public Employees Retirement System of Ohio increased its position in Embecta by 66.2% in the third quarter. Public Employees Retirement System of Ohio now owns 2,284 shares of the company’s stock worth $34,000 after purchasing an additional 910 shares during the last quarter. Signaturefd LLC increased its position in Embecta by 1,254.4% in the third quarter. Signaturefd LLC now owns 2,316 shares of the company’s stock worth $35,000 after purchasing an additional 2,145 shares during the last quarter. National Bank of Canada FI increased its position in Embecta by 187.9% in the third quarter. National Bank of Canada FI now owns 2,775 shares of the company’s stock worth $44,000 after purchasing an additional 1,811 shares during the last quarter. NBC Securities Inc. bought a new stake in Embecta in the third quarter worth $44,000. Finally, Allworth Financial LP increased its position in Embecta by 200.1% during the third quarter. Allworth Financial LP now owns 3,280 shares of the company’s stock valued at $49,000 after acquiring an additional 2,187 shares during the last quarter. Hedge funds and other institutional investors own 93.83% of the company’s stock.

Insider Buying and Selling at Embecta

In other news, Director David F. Melcher purchased 2,000 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was acquired at an average cost of $16.25 per share, with a total value of $32,500.00. Following the completion of the transaction, the director now owns 45,080 shares in the company, valued at approximately $732,550. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.28% of the company’s stock.

Embecta Stock Down 4.5 %

EMBC stock opened at $10.40 on Friday. Embecta Corp. has a twelve month low of $9.93 and a twelve month high of $32.00. The stock has a market capitalization of $598.83 million, a price-to-earnings ratio of 10.95 and a beta of 0.73. The firm’s fifty day simple moving average is $12.81 and its two-hundred day simple moving average is $15.45.

Embecta (NASDAQ:EMBC) last posted its quarterly earnings data on Friday, February 9th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.15. The business had revenue of $277.30 million for the quarter, compared to analysts’ expectations of $264.92 million. Embecta had a net margin of 4.93% and a negative return on equity of 18.66%. The business’s revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.93 earnings per share. As a group, equities research analysts expect that Embecta Corp. will post 2.14 EPS for the current year.

Embecta Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Wednesday, February 28th were paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 5.77%. The ex-dividend date was Tuesday, February 27th. Embecta’s dividend payout ratio (DPR) is presently 63.16%.

Embecta Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.